Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 |
filingDate |
2010-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2012-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2012518014-A |
titleOfInvention |
Use of G-CSF to extend the therapeutic time of thrombolytic therapy for stroke |
abstract |
The present invention extends the treatable time of subsequent thrombolytic treatment of acute stroke, thereby making the necessary diagnosis prior to thrombolytic treatment to avoid hemorrhagic side effects and other serious adverse side effects of thrombolysis It relates to the use of G-CSF and its derivatives that allow testing. |
priorityDate |
2009-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |